Navigation Links
World Congress on Industrial Biotechnology: Germany Home to Top Biotech Research and Investment

BERLIN, April 25 /PRNewswire/ -- Processes and products based on biomass and industrial biotechnology offer significant business potential for the chemical industry in a wide range of applications such as bioplastics. A panel on developments in the field of industrial biotechnology in Germany will be held at the World Congress on Industrial Biotechnology and Bioprocessing (April 27-30, 2008) in Chicago, Illinois. The panel runs from 10:45am to 12:15pm on April 28th at the Hilton Chicago, 720 South Michigan Ave.

Research institutes play a pivotal role in biotechnology investments, and they are particularly strong in Germany as the country has many internationally recognized research centers. Dr. Steffen Rupp is the Head of Molecular Biotechnology of Fraunhofer IGB at the Fraunhofer Campus Stuttgart. His laboratory is a part of the wider network of Fraunhofer Institutes, a world-renowned research organization with affiliate centers all over Germany. He will discuss renewable feedstock such as residual biomass and ways of transforming such biomass into practical energy sources.

Chemical parks are a major attraction to Germany for the chemicals and biotechnology industries. Dr. Markus Wolperdinger is in charge of industrial biotech activities at InfraLeuna GmbH. InfraLeuna is the owner and infrastructure provider of one of Germany's largest chemical sites. The Leuna chemical site is home to over 100 companies, including some of the world's top chemical companies. Dr. Wolperdinger will discuss activities in the industrial biotechnology field that are currently taking place at the Leuna chemical site.

Dr. Karin Bronnenmeier will discuss the transfer of knowledge from fossil based refineries to future biorefineries. Specifically the integration of biotech expertise from biopharma biotech will be the focus of her presentation. She is the "know-how" manager for Biotechnology Plants at Linde-KCA-Dresden, the Competence Center Biotechnology at Linde's engineering division. The Linde Group is a leading gases and engineering company with 50,000 employees in over 70 countries.

Germany has the largest market in Europe for both the chemical industry and thermoplastics. The panel will address investment possibilities in Germany in a diversity of sectors, such as biotechnology and bioplastic.

Invest in Germany is the inward investment promotion agency of the Federal Republic of Germany. It provides investors with comprehensive support from site selection to the implementation of investment decisions.

Media Contact:

Eva Henkel

Invest in Germany

Phone: +49-30-200099-173

Fax: +49-30-200099-111


SOURCE Invest in Germany
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in Sirtuin Research and Development
2. febit to Introduce Geniom RT Analyzer(R) to U.S. Market at RNAi World Congress
3. Novavax CEO to Present at the World Vaccine Congress 2008
4. BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance
5. Graphene used to create worlds smallest transistor
6. BioSpace and IBC Life Sciences Announce Career Fair Alliance For Drug Discovery & Development of Innovative Therapeutics World Congress
7. Researchers create the first thermal nanomotor in the world
8. WorldHeart 10-KSB Audit Report Includes Going Concern Qualification
9. Real-World Data from ARRIVE Registries Show Favorable Outcomes for TAXUS(R) Express(TM) Stent
10. CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide
11. Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide
Post Your Comments:
(Date:10/12/2017)... NY (PRWEB) , ... October 12, 2017 , ... ... of Sciences today announced the three Winners and six Finalists of the 2017 ... given annually by the Blavatnik Family Foundation and administered by the New York ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the first-ever genomics analysis platform specifically designed for life science researchers to ... of pioneering researcher Rosalind Franklin, who made a major contribution to the ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... announced today it will be hosting a Webinar titled, “Pathology is going digital. ... Associates , on digital pathology adoption best practices and how Proscia improves lab ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):